News

With third bio-train complete, Catalent eyes fourth and fifth in Wisconsin
Facilities & Capacity
With third bio-train complete, Catalent eyes fourth and fifth in WisconsinWith third bio-train complete, Catalent eyes fourth and fifth in Wisconsin

byDan Stanton
Aug 31, 2018
|
2 Min Read
Sartorius opening life sciences launchpad to grow German talent and innovation
Upstream & Downstream Processing
Sartorius opening life sciences launchpad to grow German talent and innovationSartorius opening life sciences launchpad to grow German talent and innovation
byBPI Staff
Aug 31, 2018
2 Min Read
Gilead says CA plant will supply Yescarta to EU until 2020
Global Markets
Gilead says CA plant will supply Yescarta to EU until 2020Gilead says CA plant will supply Yescarta to EU until 2020
byDan Stanton
Aug 30, 2018
2 Min Read
AGC Bio adding 12,000L of ‘competitive and flexible’ capacity in Denmark
Upstream & Downstream Processing
AGC Bio adding 12,000L of ‘competitive and flexible’ capacity in DenmarkAGC Bio adding 12,000L of ‘competitive and flexible’ capacity in Denmark
byDan Stanton
Aug 29, 2018
2 Min Read
Samsung BioLogics says biosimilars important to utilize growing capacity
Facilities & Capacity
Samsung BioLogics says biosimilars important to utilize growing capacitySamsung BioLogics says biosimilars important to utilize growing capacity
byDan Stanton
Aug 29, 2018
2 Min Read
Novartis constructing $92m CAR-T plant as Kymriah arrives in EU
Bioprocess Insider
Novartis constructing $92m CAR-T plant as Kymriah arrives in EUNovartis constructing $92m CAR-T plant as Kymriah arrives in EU
byDan Stanton
Aug 28, 2018
3 Min Read
Bioreactors from Ireland to China: ABEC gains second license
Bioprocess Insider
Bioreactors from Ireland to China: ABEC gains second license
Bioreactors from Ireland to China: ABEC gains second license
Aug 28, 2018
|
2 Min Read
byDan Stanton
Kyowa Hakko fermentation plant hit with FDA warning
Regulations
Kyowa Hakko fermentation plant hit with FDA warning
Kyowa Hakko fermentation plant hit with FDA warning
Aug 24, 2018
|
2 Min Read
byBPI Staff
Freedom of innovation: GE opens $17m Swedish biotech testing center
Upstream & Downstream Processing
Freedom of innovation: GE opens $17m Swedish biotech testing center
Freedom of innovation: GE opens $17m Swedish biotech testing center
Aug 24, 2018
|
2 Min Read
byDan Stanton
US made biosimilars: Competitive advantage or marketing spin?
Global Markets
US made biosimilars: Competitive advantage or marketing spin?
US made biosimilars: Competitive advantage or marketing spin?
Aug 22, 2018
|
3 Min Read
byDan Stanton
Ex-Shire director to aid Catalent’s shift to commercial manufacturing
Bioprocess Insider
Ex-Shire director to aid Catalent’s shift to commercial manufacturing
Ex-Shire director to aid Catalent’s shift to commercial manufacturing
Aug 16, 2018
|
3 Min Read
byDan Stanton
Jazz scales back Erwinaze push due to manufacturing disruptions
Regulations
Jazz scales back Erwinaze push due to manufacturing disruptions
Jazz scales back Erwinaze push due to manufacturing disruptions
Aug 16, 2018
|
2 Min Read
byDan Stanton
YMC M&A: Lewa addition brings bioprocess tech and US market
Bioprocess Insider
YMC M&A: Lewa addition brings bioprocess tech and US market
YMC M&A: Lewa addition brings bioprocess tech and US market
Aug 14, 2018
|
2 Min Read
byDan Stanton
Samsung Bioepis: From biosimilars to novel biologics
Therapeutic Class
Samsung Bioepis: From biosimilars to novel biologics
Samsung Bioepis: From biosimilars to novel biologics
Aug 13, 2018
|
3 Min Read
byDan Stanton
Alnylam’s success brings first RNAi therapeutic to US
Therapeutic Class
Alnylam’s success brings first RNAi therapeutic to US
Alnylam’s success brings first RNAi therapeutic to US
Aug 13, 2018
|
2 Min Read
byDan Stanton
Emergent: $270m PaxVax acquisition and Baltimore expansion boost CDMO biz
Bioprocess Insider
Emergent: $270m PaxVax acquisition and Baltimore expansion boost CDMO biz
Emergent: $270m PaxVax acquisition and Baltimore expansion boost CDMO biz
Aug 10, 2018
|
3 Min Read
byBPI Staff
MilliporeSigma partners Innocore for sustained release tech
Deal-Making
MilliporeSigma partners Innocore for sustained release tech
MilliporeSigma partners Innocore for sustained release tech
Aug 9, 2018
|
2 Min Read
byDan Stanton
Celltrion receives FDA 483 with 8 ‘manageable and correctible��’ observations
Regulations
Celltrion receives FDA 483 with 8 ‘manageable and correctible’ observations
Celltrion receives FDA 483 with 8 ‘manageable and correctible’ observations
Aug 8, 2018
|
2 Min Read
byDan Stanton
Anti-antibody anybody? Bio-Rad range to target Lucentis biosimilar developers
Bioprocess Insider
Anti-antibody anybody? Bio-Rad range to target Lucentis biosimilar developers
Anti-antibody anybody? Bio-Rad range to target Lucentis biosimilar developers
Aug 7, 2018
|
2 Min Read
byDan Stanton
Repligen riding high on Protein A strategic partnerships
Upstream & Downstream Processing
Repligen riding high on Protein A strategic partnerships
Repligen riding high on Protein A strategic partnerships
Aug 7, 2018
|
2 Min Read
byDan Stanton
Regeneron teams up and takes $100m stake in bluebird bio
Deal-Making
Regeneron teams up and takes $100m stake in bluebird bio
Regeneron teams up and takes $100m stake in bluebird bio
Aug 6, 2018
|
2 Min Read
byDan Stanton
Esco Aster to transfer CAR-T tech to Chinese biomanufacturing plant
Global Markets
Esco Aster to transfer CAR-T tech to Chinese biomanufacturing plant
Esco Aster to transfer CAR-T tech to Chinese biomanufacturing plant
Aug 6, 2018
|
2 Min Read
byDan Stanton
BioTime spinning out regenerative med firm AgeX
Deal-Making
BioTime spinning out regenerative med firm AgeX
BioTime spinning out regenerative med firm AgeX
Aug 3, 2018
|
2 Min Read
byDan Stanton
Amgen Breaks Ground on $160m Rhode Island Plant
Global Markets
Amgen Breaks Ground on $160m Rhode Island Plant
Amgen Breaks Ground on $160m Rhode Island Plant
Jul 31, 2018
|
2 Min Read
byDan Stanton
Q2 Results: Bioprocessing Vendors Return to Double-Digit Growth
Upstream & Downstream Processing
Q2 Results: Bioprocessing Vendors Return to Double-Digit Growth
Q2 Results: Bioprocessing Vendors Return to Double-Digit Growth
Jul 31, 2018
|
2 Min Read
byDan Stanton
Lonza: CAR-T Manufacturing Glitch an Industry Problem, not Just Novartis’s
Therapeutic Class
Lonza: CAR-T Manufacturing Glitch an Industry Problem, not Just Novartis’s
Lonza: CAR-T Manufacturing Glitch an Industry Problem, not Just Novartis’s
Jul 30, 2018
|
2 Min Read
byDan Stanton
Bioproduction: A ‘Tale of Two Facilities,’ Says Jacobs
Facilities & Capacity
Bioproduction: A ‘Tale of Two Facilities,’ Says Jacobs
Bioproduction: A ‘Tale of Two Facilities,’ Says Jacobs
Jul 30, 2018
|
2 Min Read
byDan Stanton
Plant Round-Up: Rubius Buys, WuXi Begins, Samsung Approved
Facilities & Capacity
Plant Round-Up: Rubius Buys, WuXi Begins, Samsung Approved
Plant Round-Up: Rubius Buys, WuXi Begins, Samsung Approved
Jul 27, 2018
|
2 Min Read
byBPI Staff
Sangamo Bets on CAR-Treg Through $84m TxCell Acquisition
Deal-Making
Sangamo Bets on CAR-Treg Through $84m TxCell Acquisition
Sangamo Bets on CAR-Treg Through $84m TxCell Acquisition
Jul 27, 2018
|
2 Min Read
byDan Stanton
FDA Greasing the Wheel for Biosimilar Adoption Through Action Plan
Therapeutic Class
FDA Greasing the Wheel for Biosimilar Adoption Through Action Plan
FDA Greasing the Wheel for Biosimilar Adoption Through Action Plan
Jul 25, 2018
|
3 Min Read
byDan Stanton
Neupogen Biosimilar Success: Pfizer Banks on Discounts and Patient Confidence
Global Markets
Neupogen Biosimilar Success: Pfizer Banks on Discounts and Patient Confidence
Neupogen Biosimilar Success: Pfizer Banks on Discounts and Patient Confidence
Jul 24, 2018
|
2 Min Read
byDan Stanton
Danaher Praises Pall for Returning Biopharma to ‘High Growth Norm’
Upstream & Downstream Processing
Danaher Praises Pall for Returning Biopharma to ‘High Growth Norm’
Danaher Praises Pall for Returning Biopharma to ‘High Growth Norm’
Jul 23, 2018
|
2 Min Read
byDan Stanton
Pluristem and Thermo Fisher Look to Plug Gaps in Cell Therapy Manufacture
Upstream & Downstream Processing
Pluristem and Thermo Fisher Look to Plug Gaps in Cell Therapy Manufacture
Pluristem and Thermo Fisher Look to Plug Gaps in Cell Therapy Manufacture
Jul 20, 2018
|
2 Min Read
byDan Stanton
Univercells $19m Booster Shot to Help Disrupt Vaccine Industry
Bioprocess Insider
Univercells $19m Booster Shot to Help Disrupt Vaccine Industry
Univercells $19m Booster Shot to Help Disrupt Vaccine Industry
Jul 20, 2018
|
3 Min Read
byDan Stanton
'Dramatic' Gene Therapy Demand Drives Viral Vector Delays
Facilities & Capacity
'Dramatic' Gene Therapy Demand Drives Viral Vector Delays
'Dramatic' Gene Therapy Demand Drives Viral Vector Delays
Jul 20, 2018
|
2 Min Read
byDan Stanton

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024